FDA says a Surmodics PMA for its SurVeil drug-coated balloon to treat peripheral artery disease is not currently approvable.
FDA publishes a final rule amending and repealing some radiological health regulations.
FDA posts a draft guidance entitled Mpox: Development of Drugs and Biological Products.
FDA asks a Florida federal court for an injunction against LGM Pharma to ensure that it no longer holds and ships adulterated drugs.
FDA releases the form FDA-483 with 11 observations from an inspection at Indias Intas Pharmaceuticals.
FDA clears a Realize Medical 510(k) for its Elucis virtual reality software for surgical planning.
FDA commissioner Robert Califf says FDA has a key role to play in reshaping the nations system for generating medical evidence to support new treatmen...
FDA sends Eli Lilly a complete response letter for its accelerated approval BLA submission for donanemab, indicated for treating early symptomatic Alz...